Microbial and metabolic interactions between the gastrointestinal tract and Clostridium difficile infection

References

• Hall JC, O'Toole E. Intestinal flora in new-born infants with a description of a new pathogenic anaerobe, Bacillus difficilis.. Am J Dis Child 1935; 49:390 - 402; http://dx.doi.org/10.1001/archpedi.1935.01970020105010
   Google Scholar
• Bartlett JG, Gorbach SL. Pseudomembranous enterocolitis (antibiotic-related colitis). Adv Intern Med 1977; 22:455 - 76; PMID: 320848
   PubMedGoogle Scholar
• Dubberke ER, Olsen MA. Burden of Clostridium difficile on the healthcare system. Clin Infect Dis 2012; 55:Suppl 2 S88 - 92; http://dx.doi.org/10.1093/cid/cis335; PMID: 22752870
   PubMed Web of Science ®Google Scholar
• Lucado J, Gould C, Elixhauser A. in Healthcare Cost and Utilization Project (HCUP) Statistical Briefs (2006).
   Google Scholar
• Bartlett JG, Gerding DN. Clinical recognition and diagnosis of Clostridium difficile infection.. Clin Infect Dis 2008; 46:Suppl 1 S12 - 8; http://dx.doi.org/10.1086/521863; PMID: 18177217
   PubMed Web of Science ®Google Scholar
• Freeman J, Wilcox MH. Antibiotics and Clostridium difficile.. Microbes Infect 1999; 1:377 - 84; http://dx.doi.org/10.1016/S1286-4579(99)80054-9; PMID: 10602670
   PubMed Web of Science ®Google Scholar
• Pépin J, Saheb N, Coulombe MA, Alary ME, Corriveau MP, Authier S, Leblanc M, Rivard G, Bettez M, Primeau V, et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis 2005; 41:1254 - 60; http://dx.doi.org/10.1086/496986; PMID: 16206099
   PubMed Web of Science ®Google Scholar
• Baxter R, Ray GT, Fireman BH. Case-control study of antibiotic use and subsequent Clostridium difficile-associated diarrhea in hospitalized patients. Infect Control Hosp Epidemiol 2008; 29:44 - 50; http://dx.doi.org/10.1086/524320; PMID: 18171186
   PubMed Web of Science ®Google Scholar
• Gifford AH, Kirkland KB. Risk factors for Clostridium difficile-associated diarrhea on an adult hematology-oncology ward. Eur J Clin Microbiol Infect Dis 2006; 25:751 - 5; http://dx.doi.org/10.1007/s10096-006-0220-1; PMID: 17072575
   PubMed Web of Science ®Google Scholar
• McFarland LV. Antibiotic-associated diarrhea: epidemiology, trends and treatment. Future Microbiol 2008; 3:563 - 78; http://dx.doi.org/10.2217/17460913.3.5.563; PMID: 18811240
   PubMed Web of Science ®Google Scholar
• van der Waaij D, Berghuis-de Vries JM, Lekkerkerk Lekkerkerk-v. Colonization resistance of the digestive tract in conventional and antibiotic-treated mice. J Hyg (Lond) 1971; 69:405 - 11; http://dx.doi.org/10.1017/S0022172400021653; PMID: 4999450
   PubMedGoogle Scholar
• Vollaard EJ, Clasener HA. Colonization resistance. Antimicrob Agents Chemother 1994; 38:409 - 14; http://dx.doi.org/10.1128/AAC.38.3.409; PMID: 8203832
   PubMed Web of Science ®Google Scholar
• Antonopoulos DA, Huse SM, Morrison HG, Schmidt TM, Sogin ML, Young VB. Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation. Infect Immun 2009; 77:2367 - 75; http://dx.doi.org/10.1128/IAI.01520-08; PMID: 19307217
   PubMed Web of Science ®Google Scholar
• Dethlefsen L, Huse S, Sogin ML, Relman DA. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 2008; 6:e280; http://dx.doi.org/10.1371/journal.pbio.0060280; PMID: 19018661
   PubMed Web of Science ®Google Scholar
• Cho I, Yamanishi S, Cox L, Methé BA, Zavadil J, Li K, Gao Z, Mahana D, Raju K, Teitler I, et al. Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature 2012; 488:621 - 6; http://dx.doi.org/10.1038/nature11400; PMID: 22914093
   PubMed Web of Science ®Google Scholar
• Antunes LC, Han J, Ferreira RB, Lolić P, Borchers CH, Finlay BB. Effect of antibiotic treatment on the intestinal metabolome. Antimicrob Agents Chemother 2011; 55:1494 - 503; http://dx.doi.org/10.1128/AAC.01664-10; PMID: 21282433
   PubMed Web of Science ®Google Scholar
• Kinross JM, Darzi AW, Nicholson JK. Gut microbiome-host interactions in health and disease. Genome Med 2011; 3:14; http://dx.doi.org/10.1186/gm228; PMID: 21392406
   PubMed Web of Science ®Google Scholar
• Swann JR, Want EJ, Geier FM, Spagou K, Wilson ID, Sidaway JE, Nicholson JK, Holmes E. Systemic gut microbial modulation of bile acid metabolism in host tissue compartments. Proc Natl Acad Sci U S A 2011; 108:Suppl 1 4523 - 30; http://dx.doi.org/10.1073/pnas.1006734107; PMID: 20837534
   PubMed Web of Science ®Google Scholar
• Sorg JA, Sonenshein AL. Bile salts and glycine as cogerminants for Clostridium difficile spores. J Bacteriol 2008; 190:2505 - 12; http://dx.doi.org/10.1128/JB.01765-07; PMID: 18245298
   PubMed Web of Science ®Google Scholar
• Karlsson S, Burman LG, Akerlund T. Induction of toxins in Clostridium difficile is associated with dramatic changes of its metabolism. Microbiology 2008; 154:3430 - 6; http://dx.doi.org/10.1099/mic.0.2008/019778-0; PMID: 18957596
   PubMed Web of Science ®Google Scholar
• Nakamura S, Nakashio S, Yamakawa K, Tanabe N, Nishida S. Carbohydrate fermentation by Clostridium difficile.. Microbiol Immunol 1982; 26:107 - 11; http://dx.doi.org/10.1111/j.1348-0421.1982.tb00159.x; PMID: 6806571
   PubMed Web of Science ®Google Scholar
• Giel JL, Sorg JA, Sonenshein AL, Zhu J. Metabolism of bile salts in mice influences spore germination in Clostridium difficile.. PLoS One 2010; 5:e8740; http://dx.doi.org/10.1371/journal.pone.0008740; PMID: 20090901
   PubMed Web of Science ®Google Scholar
• Savage DC. Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol 1977; 31:107 - 33; http://dx.doi.org/10.1146/annurev.mi.31.100177.000543; PMID: 334036
   PubMed Web of Science ®Google Scholar
• Freter R. In vivo and in vitro antagonism of intestinal bacteria against Shigellaflexneri. II. The inhibitory mechanism. J Infect Dis 1962; 110:38 - 46; http://dx.doi.org/10.1093/infdis/110.1.38; PMID: 13895061
   PubMed Web of Science ®Google Scholar
• Gill SR, Pop M, Deboy RT, Eckburg PB, Turnbaugh PJ, Samuel BS, Gordon JI, Relman DA, Fraser-Liggett CM, Nelson KE. Metagenomic analysis of the human distal gut microbiome. Science 2006; 312:1355 - 9; http://dx.doi.org/10.1126/science.1124234; PMID: 16741115
   PubMed Web of Science ®Google Scholar
• Sonnenburg JL, Xu J, Leip DD, Chen CH, Westover BP, Weatherford J, Buhler JD, Gordon JI. Glycan foraging in vivo by an intestine-adapted bacterial symbiont. Science 2005; 307:1955 - 9; http://dx.doi.org/10.1126/science.1109051; PMID: 15790854
   PubMed Web of Science ®Google Scholar
• Flint HJ, Scott KP, Duncan SH, Louis P, Forano E. Microbial degradation of complex carbohydrates in the gut. Gut Microbes 2012; 3:289 - 306; http://dx.doi.org/10.4161/gmic.19897; PMID: 22572875
   PubMed Web of Science ®Google Scholar
• Rogers TE, Pudlo NA, Koropatkin NM, Bell JS, Moya Balasch M, Jasker K, Martens EC. Dynamic responses of Bacteroides thetaiotaomicron during growth on glycan mixtures. Mol Microbiol 2013; 88:876 - 90; http://dx.doi.org/10.1111/mmi.12228; PMID: 23646867
   PubMed Web of Science ®Google Scholar
• Dai ZL, Wu G, Zhu WY. Amino acid metabolism in intestinal bacteria: links between gut ecology and host health. Front Biosci (Landmark Ed) 2011; 16:1768 - 86; http://dx.doi.org/10.2741/3820; PMID: 21196263
   PubMed Web of Science ®Google Scholar
• Cummings JH, Macfarlane GT. The control and consequences of bacterial fermentation in the human colon. J Appl Bacteriol 1991; 70:443 - 59; http://dx.doi.org/10.1111/j.1365-2672.1991.tb02739.x; PMID: 1938669
   PubMedGoogle Scholar
• Silvester KR, Englyst HN, Cummings JH. Ileal recovery of starch from whole diets containing resistant starch measured in vitro and fermentation of ileal effluent. Am J Clin Nutr 1995; 62:403 - 11; PMID: 7625349
   PubMed Web of Science ®Google Scholar
• Macfarlane GT, Macfarlane S. Bacteria, colonic fermentation, and gastrointestinal health. J AOAC Int 2012; 95:50 - 60; http://dx.doi.org/10.5740/jaoacint.SGE_Macfarlane; PMID: 22468341
   PubMed Web of Science ®Google Scholar
• Stecher B, Hardt WD. Mechanisms controlling pathogen colonization of the gut. Curr Opin Microbiol 2011; 14:82 - 91; http://dx.doi.org/10.1016/j.mib.2010.10.003; PMID: 21036098
   PubMed Web of Science ®Google Scholar
• Dai ZL, Wu G, Zhu WY. Amino acid metabolism in intestinal bacteria: links between gut ecology and host health. Front Biosci (Landmark Ed) 2011; 16:1768 - 86; http://dx.doi.org/10.2741/3820; PMID: 21196263
   PubMed Web of Science ®Google Scholar
• Canani RB, Costanzo MD, Leone L, Pedata M, Meli R, Calignano A. Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World J Gastroenterol 2011; 17:1519 - 28; http://dx.doi.org/10.3748/wjg.v17.i12.1519; PMID: 21472114
   PubMed Web of Science ®Google Scholar
• Ridlon JM, Kang DJ, Hylemon PB. Bile salt biotransformations by human intestinal bacteria. J Lipid Res 2006; 47:241 - 59; http://dx.doi.org/10.1194/jlr.R500013-JLR200; PMID: 16299351
   PubMed Web of Science ®Google Scholar
• Chiang JY. Bile acids: regulation of synthesis. J Lipid Res 2009; 50:1955 - 66; http://dx.doi.org/10.1194/jlr.R900010-JLR200; PMID: 19346330
   PubMed Web of Science ®Google Scholar
• Midtvedt T. Microbial bile acid transformation. Am J Clin Nutr 1974; 27:1341 - 7; PMID: 4217103
   PubMed Web of Science ®Google Scholar
• Wells JE, Hylemon PB. Identification and characterization of a bile acid 7alpha-dehydroxylation operon in Clostridium sp. strain TO-931, a highly active 7alpha-dehydroxylating strain isolated from human feces. Appl Environ Microbiol 2000; 66:1107 - 13; http://dx.doi.org/10.1128/AEM.66.3.1107-1113.2000; PMID: 10698778
   PubMed Web of Science ®Google Scholar
• Hill DA, Hoffmann C, Abt MC, Du Y, Kobuley D, Kirn TJ, Bushman FD, Artis D. Metagenomic analyses reveal antibiotic-induced temporal and spatial changes in intestinal microbiota with associated alterations in immune cell homeostasis. Mucosal Immunol 2010; 3:148 - 58; http://dx.doi.org/10.1038/mi.2009.132; PMID: 19940845
   PubMed Web of Science ®Google Scholar
• Antonopoulos DA, Huse SM, Morrison HG, Schmidt TM, Sogin ML, Young VB. Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation. Infect Immun 2009; 77:2367 - 75; http://dx.doi.org/10.1128/IAI.01520-08; PMID: 19307217
   PubMed Web of Science ®Google Scholar
• Young VB, Schmidt TM. Antibiotic-associated diarrhea accompanied by large-scale alterations in the composition of the fecal microbiota. J Clin Microbiol 2004; 42:1203 - 6; http://dx.doi.org/10.1128/JCM.42.3.1203-1206.2004; PMID: 15004076
   PubMed Web of Science ®Google Scholar
• Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci U S A 2011; 108:Suppl 1 4554 - 61; http://dx.doi.org/10.1073/pnas.1000087107; PMID: 20847294
   PubMed Web of Science ®Google Scholar
• Zhao Y, Wu J, Li JV, Zhou NY, Tang H, Wang Y. Gut microbiota composition modifies fecal metabolic profiles in mice. J Proteome Res 2013; 12:2987 - 99; http://dx.doi.org/10.1021/pr400263n; PMID: 23631562
   PubMed Web of Science ®Google Scholar
• Yap IK, Li JV, Saric J, Martin FP, Davies H, Wang Y, Wilson ID, Nicholson JK, Utzinger J, Marchesi JR, et al. Metabonomic and microbiological analysis of the dynamic effect of vancomycin-induced gut microbiota modification in the mouse. J Proteome Res 2008; 7:3718 - 28; http://dx.doi.org/10.1021/pr700864x; PMID: 18698804
   PubMed Web of Science ®Google Scholar
• Romick-Rosendale LE, Goodpaster AM, Hanwright PJ, Patel NB, Wheeler ET, Chona DL, Kennedy MA. NMR-based metabonomics analysis of mouse urine and fecal extracts following oral treatment with the broad-spectrum antibiotic enrofloxacin (Baytril). Magn Reson Chem 2009; 47:Suppl 1 S36 - 46; http://dx.doi.org/10.1002/mrc.2511; PMID: 19768747
   PubMed Web of Science ®Google Scholar
• Zheng X, Xie G, Zhao A, Zhao L, Yao C, Chiu NH, Zhou Z, Bao Y, Jia W, Nicholson JK, et al. The footprints of gut microbial-mammalian co-metabolism. J Proteome Res 2011; 10:5512 - 22; http://dx.doi.org/10.1021/pr2007945; PMID: 21970572
   PubMed Web of Science ®Google Scholar
• Høverstad T, Carlstedt-Duke B, Lingaas E, Midtvedt T, Norin KE, Saxerholt H, Steinbakk M. Influence of ampicillin, clindamycin, and metronidazole on faecal excretion of short-chain fatty acids in healthy subjects. Scand J Gastroenterol 1986; 21:621 - 6; http://dx.doi.org/10.3109/00365528609003109; PMID: 3749800
   PubMed Web of Science ®Google Scholar
• Wilson KH, Kennedy MJ, Fekety FR. Use of sodium taurocholate to enhance spore recovery on a medium selective for Clostridium difficile.. J Clin Microbiol 1982; 15:443 - 6; PMID: 7076817
   PubMed Web of Science ®Google Scholar
• Wilson KH. Efficiency of various bile salt preparations for stimulation of Clostridium difficile spore germination. J Clin Microbiol 1983; 18:1017 - 9; PMID: 6630458
   PubMed Web of Science ®Google Scholar
• Sorg JA, Sonenshein AL. Inhibiting the initiation of Clostridium difficile spore germination using analogs of chenodeoxycholic acid, a bile acid. J Bacteriol 2010; 192:4983 - 90; http://dx.doi.org/10.1128/JB.00610-10; PMID: 20675492
   PubMed Web of Science ®Google Scholar
• Sorg JA, Sonenshein AL. Chenodeoxycholate is an inhibitor of Clostridium difficile spore germination. J Bacteriol 2009; 191:1115 - 7; http://dx.doi.org/10.1128/JB.01260-08; PMID: 19060152
   PubMed Web of Science ®Google Scholar
• Wheeldon LJ, Worthington T, Lambert PA. Histidine acts as a co-germinant with glycine and taurocholate for Clostridium difficile spores. J Appl Microbiol 2011; http://dx.doi.org/10.1111/j.1365-2672.2011.04953.x; PMID: 21261795
   PubMed Web of Science ®Google Scholar
• Howerton A, Ramirez N, Abel-Santos E. Mapping interactions between germinants and Clostridium difficile spores. J Bacteriol 2011; 193:274 - 82; http://dx.doi.org/10.1128/JB.00980-10; PMID: 20971909
   PubMed Web of Science ®Google Scholar
• Heeg D, Burns DA, Cartman ST, Minton NP. Spores of Clostridium difficile clinical isolates display a diverse germination response to bile salts. PLoS One 2012; 7:e32381; http://dx.doi.org/10.1371/journal.pone.0032381; PMID: 22384234
   PubMed Web of Science ®Google Scholar
• Carlson PE Jr., Walk ST, Bourgis AE, Liu MW, Kopliku F, Lo E, Young VB, Aronoff DM, Hanna PC. The relationship between phenotype, ribotype, and clinical disease in human Clostridium difficile isolates. Anaerobe 2013; 24:109 - 16; http://dx.doi.org/10.1016/j.anaerobe.2013.04.003; PMID: 23608205
   PubMed Web of Science ®Google Scholar
• Sayin SI, Wahlström A, Felin J, Jäntti S, Marschall HU, Bamberg K, Angelin B, Hyötyläinen T, Orešič M, Bäckhed F. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab 2013; 17:225 - 35; http://dx.doi.org/10.1016/j.cmet.2013.01.003; PMID: 23395169
   PubMed Web of Science ®Google Scholar
• Köpke M, Straub M, Dürre P. Clostridium difficile is an autotrophic bacterial pathogen. PLoS One 2013; 8:e62157; http://dx.doi.org/10.1371/journal.pone.0062157; PMID: 23626782
   PubMed Web of Science ®Google Scholar
• Poilane I, Karjalainen T, Barc MC, Bourlioux P, Collignon A. Protease activity of Clostridium difficile strains. Can J Microbiol 1998; 44:157 - 61; PMID: 9543717
   PubMed Web of Science ®Google Scholar
• Karasawa T, Ikoma S, Yamakawa K, Nakamura S. A defined growth medium for Clostridium difficile.. Microbiology 1995; 141:371 - 5; http://dx.doi.org/10.1099/13500872-141-2-371; PMID: 7704267
   PubMed Web of Science ®Google Scholar
• Bouillaut L, Self WT, Sonenshein AL. Proline-dependent regulation of Clostridium difficile Stickland metabolism. J Bacteriol 2013; 195:844 - 54; http://dx.doi.org/10.1128/JB.01492-12; PMID: 23222730
   PubMed Web of Science ®Google Scholar
• Karlsson S, Lindberg A, Norin E, Burman LG, Akerlund T. Toxins, butyric acid, and other short-chain fatty acids are coordinately expressed and down-regulated by cysteine in Clostridium difficile.. Infect Immun 2000; 68:5881 - 8; http://dx.doi.org/10.1128/IAI.68.10.5881-5888.2000; PMID: 10992498
   PubMed Web of Science ®Google Scholar
• Antunes A, Martin-Verstraete I, Dupuy B. CcpA-mediated repression of Clostridium difficile toxin gene expression. Mol Microbiol 2011; 79:882 - 99; http://dx.doi.org/10.1111/j.1365-2958.2010.07495.x; PMID: 21299645
   PubMed Web of Science ®Google Scholar
• Dupuy B, Sonenshein AL. Regulated transcription of Clostridium difficile toxin genes. Mol Microbiol 1998; 27:107 - 20; http://dx.doi.org/10.1046/j.1365-2958.1998.00663.x; PMID: 9466260
   PubMed Web of Science ®Google Scholar
• Karasawa T, Maegawa T, Nojiri T, Yamakawa K, Nakamura S. Effect of arginine on toxin production by Clostridium difficile in defined medium. Microbiol Immunol 1997; 41:581 - 5; http://dx.doi.org/10.1111/j.1348-0421.1997.tb01895.x; PMID: 9310936
   PubMed Web of Science ®Google Scholar
• Ikeda D, Karasawa T, Yamakawa K, Tanaka R, Namiki M, Nakamura S. Effect of isoleucine on toxin production by Clostridium difficile in a defined medium. Zentralbl Bakteriol 1998; 287:375 - 86; http://dx.doi.org/10.1016/S0934-8840(98)80174-6; PMID: 9638867
   PubMedGoogle Scholar
• Karlsson S, Lindberg A, Norin E, Burman LG, Akerlund T. Toxins, butyric acid, and other short-chain fatty acids are coordinately expressed and down-regulated by cysteine in Clostridium difficile.. Infect Immun 2000; 68:5881 - 8; http://dx.doi.org/10.1128/IAI.68.10.5881-5888.2000; PMID: 10992498
   PubMed Web of Science ®Google Scholar
• Yamakawa K, Karasawa T, Ikoma S, Nakamura S. Enhancement of Clostridium difficile toxin production in biotin-limited conditions. J Med Microbiol 1996; 44:111 - 4; http://dx.doi.org/10.1099/00222615-44-2-111; PMID: 8642571
   PubMed Web of Science ®Google Scholar
• Dineen SS, Villapakkam AC, Nordman JT, Sonenshein AL. Repression of Clostridium difficile toxin gene expression by CodY. Mol Microbiol 2007; 66:206 - 19; http://dx.doi.org/10.1111/j.1365-2958.2007.05906.x; PMID: 17725558
   PubMed Web of Science ®Google Scholar
• Dineen SS, McBride SM, Sonenshein AL. Integration of metabolism and virulence by Clostridium difficile CodY. J Bacteriol 2010; 192:5350 - 62; http://dx.doi.org/10.1128/JB.00341-10; PMID: 20709897
   PubMed Web of Science ®Google Scholar
• Braun V, Hundsberger T, Leukel P, Sauerborn M, von Eichel-Streiber C. Definition of the single integration site of the pathogenicity locus in Clostridium difficile.. Gene 1996; 181:29 - 38; http://dx.doi.org/10.1016/S0378-1119(96)00398-8; PMID: 8973304
   PubMed Web of Science ®Google Scholar
• Hammond GA, Lyerly DM, Johnson JL. Transcriptional analysis of the toxigenic element of Clostridium difficile.. Microb Pathog 1997; 22:143 - 54; http://dx.doi.org/10.1006/mpat.1996.0100; PMID: 9075217
   PubMed Web of Science ®Google Scholar
• Antunes A, Camiade E, Monot M, Courtois E, Barbut F, Sernova NV, Rodionov DA, Martin-Verstraete I, Dupuy B. Global transcriptional control by glucose and carbon regulator CcpA in Clostridium difficile.. Nucleic Acids Res 2012; 40:10701 - 18; http://dx.doi.org/10.1093/nar/gks864; PMID: 22989714
   PubMed Web of Science ®Google Scholar
• Antunes A, Martin-Verstraete I, Dupuy B. CcpA-mediated repression of Clostridium difficile toxin gene expression. Mol Microbiol 2011; 79:882 - 99; http://dx.doi.org/10.1111/j.1365-2958.2010.07495.x; PMID: 21299645
   PubMed Web of Science ®Google Scholar
• Janoir C, et al. Insights into the adaptive strategies and pathogenesis of Clostridium difficile from in vivo transcriptomics. Infect Immun 2013; http://dx.doi.org/10.1128/IAI.00515-13
   PubMed Web of Science ®Google Scholar
• Scaria J, Janvilisri T, Fubini S, Gleed RD, McDonough SP, Chang YF. Clostridium difficile transcriptome analysis using pig ligated loop model reveals modulation of pathways not modulated in vitro. J Infect Dis 2011; 203:1613 - 20; http://dx.doi.org/10.1093/infdis/jir112; PMID: 21592991
   PubMed Web of Science ®Google Scholar
• Wilson KH, Perini F. Role of competition for nutrients in suppression of Clostridium difficile by the colonic microflora. Infect Immun 1988; 56:2610 - 4; PMID: 3417352
   PubMed Web of Science ®Google Scholar
• Chen X, Katchar K, Goldsmith JD, Nanthakumar N, Cheknis A, Gerding DN, Kelly CP. A mouse model of Clostridium difficile-associated disease. Gastroenterology 2008; 135:1984 - 92; http://dx.doi.org/10.1053/j.gastro.2008.09.002; PMID: 18848941
   PubMed Web of Science ®Google Scholar
• Theriot CM, Koumpouras CC, Carlson PE, Bergin II, Aronoff DM, Young VB. Cefoperazone-treated mice as an experimental platform to assess differential virulence of Clostridium difficile strains. Gut Microbes 2011; 2:326 - 34; http://dx.doi.org/10.4161/gmic.19142; PMID: 22198617
   PubMed Web of Science ®Google Scholar
• Steele J, Feng H, Parry N, Tzipori S. Piglet models of acute or chronic Clostridium difficile illness. J Infect Dis 2010; 201:428 - 34; http://dx.doi.org/10.1086/649799; PMID: 20039803
   PubMed Web of Science ®Google Scholar
• Bartlett JG, Onderdonk AB, Cisneros RL, Kasper DL. Commentary: Bartlett JG, Onderdonk AB, Cisneros RL, Kasper DL. Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters. J Infect Dis 1977; 136:701.. J Infect Dis 2004; 190:202 - 9; http://dx.doi.org/10.1086/421470; PMID: 15195263
   PubMed Web of Science ®Google Scholar
• Fekety R, Silva J, Toshniwal R, Allo M, Armstrong J, Browne R, Ebright J, Rifkin G. Antibiotic-associated colitis: effects of antibiotics on Clostridium difficile and the disease in hamsters. Rev Infect Dis 1979; 1:386 - 97; http://dx.doi.org/10.1093/clinids/1.2.386; PMID: 549190
   PubMedGoogle Scholar
• Reeves AE, Theriot CM, Bergin IL, Huffnagle GB, Schloss PD, Young VB. The interplay between microbiome dynamics and pathogen dynamics in a murine model of Clostridium difficile Infection. Gut Microbes 2011; 2:145 - 58; http://dx.doi.org/10.4161/gmic.2.3.16333; PMID: 21804357
   PubMed Web of Science ®Google Scholar
• Buffie CG, Jarchum I, Equinda M, Lipuma L, Gobourne A, Viale A, Ubeda C, Xavier J, Pamer EG. Profound alterations of intestinal microbiota following a single dose of clindamycin results in sustained susceptibility to Clostridium difficile-induced colitis. Infect Immun 2012; 80:62 - 73; http://dx.doi.org/10.1128/IAI.05496-11; PMID: 22006564
   PubMed Web of Science ®Google Scholar
• Lawley TD, Clare S, Walker AW, Stares MD, Connor TR, Raisen C, Goulding D, Rad R, Schreiber F, Brandt C, et al. Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog 2012; 8:e1002995; http://dx.doi.org/10.1371/journal.ppat.1002995; PMID: 23133377
   PubMed Web of Science ®Google Scholar
• Jump RL, Li Y, Pultz MJ, Kypriotakis G, Donskey CJ. Tigecycline exhibits inhibitory activity against Clostridium difficile in the colon of mice and does not promote growth or toxin production. Antimicrob Agents Chemother 2011; 55:546 - 9; http://dx.doi.org/10.1128/AAC.00839-10; PMID: 21135181
   PubMed Web of Science ®Google Scholar
• Peterfreund GL, Vandivier LE, Sinha R, Marozsan AJ, Olson WC, Zhu J, Bushman FD. Succession in the gut microbiome following antibiotic and antibody therapies for Clostridium difficile.. PLoS One 2012; 7:e46966; http://dx.doi.org/10.1371/journal.pone.0046966; PMID: 23071679
   PubMed Web of Science ®Google Scholar
• Antharam VC, Li EC, Ishmael A, Sharma A, Mai V, Rand KH, Wang GP. Intestinal dysbiosis and depletion of butyrogenic bacteria in Clostridium difficile infection and nosocomial diarrhea. J Clin Microbiol 2013; 51:2884 - 92; http://dx.doi.org/10.1128/JCM.00845-13; PMID: 23804381
   PubMed Web of Science ®Google Scholar
• Rea MC, O’Sullivan O, Shanahan F, O’Toole PW, Stanton C, Ross RP, Hill C. Clostridium difficile carriage in elderly subjects and associated changes in the intestinal microbiota. J Clin Microbiol 2012; 50:867 - 75; http://dx.doi.org/10.1128/JCM.05176-11; PMID: 22162545
   PubMed Web of Science ®Google Scholar
• Manges AR, Labbe A, Loo VG, Atherton JK, Behr MA, Masson L, Tellis PA, Brousseau R. Comparative metagenomic study of alterations to the intestinal microbiota and risk of nosocomial Clostridum difficile-associated disease. J Infect Dis 2010; 202:1877 - 84; http://dx.doi.org/10.1086/657319; PMID: 21050115
   PubMed Web of Science ®Google Scholar
• Hopkins MJ, Macfarlane GT. Changes in predominant bacterial populations in human faeces with age and with Clostridium difficile infection. J Med Microbiol 2002; 51:448 - 54; PMID: 11990498
   PubMed Web of Science ®Google Scholar
• Skraban J., et al. Gut microbiota patterns associated with colonization of different Clostridium difficile ribotypes. PloS one 2013; 8:e58005
   PubMed Web of Science ®Google Scholar
• Chang JY, Antonopoulos DA, Kalra A, Tonelli A, Khalife WT, Schmidt TM, Young VB. Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea. J Infect Dis 2008; 197:435 - 8; http://dx.doi.org/10.1086/525047; PMID: 18199029
   PubMed Web of Science ®Google Scholar
• Maroo S, Lamont JT. Recurrent clostridium difficile.. Gastroenterology 2006; 130:1311 - 6; http://dx.doi.org/10.1053/j.gastro.2006.02.044; PMID: 16618421
   PubMed Web of Science ®Google Scholar
• Gough E, Shaikh H, Manges AR. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis 2011; 53:994 - 1002; http://dx.doi.org/10.1093/cid/cir632; PMID: 22002980
   PubMed Web of Science ®Google Scholar
• Hamilton MJ, Weingarden AR, Unno T, Khoruts A, Sadowsky MJ. High-throughput DNA sequence analysis reveals stable engraftment of gut microbiota following transplantation of previously frozen fecal bacteria. Gut Microbes 2013; 4:125 - 35; http://dx.doi.org/10.4161/gmic.23571; PMID: 23333862
   PubMedGoogle Scholar
• Kelly CR, de Leon L, Jasutkar N. Fecal microbiota transplantation for relapsing Clostridium difficile infection in 26 patients: methodology and results. J Clin Gastroenterol 2012; 46:145 - 9; http://dx.doi.org/10.1097/MCG.0b013e318234570b; PMID: 22157239
   PubMed Web of Science ®Google Scholar
• Mattila E, Uusitalo-Seppälä R, Wuorela M, Lehtola L, Nurmi H, Ristikankare M, Moilanen V, Salminen K, Seppälä M, Mattila PS, et al. Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infection. Gastroenterology 2012; 142:490 - 6; http://dx.doi.org/10.1053/j.gastro.2011.11.037; PMID: 22155369
   PubMed Web of Science ®Google Scholar
• Tvede M, Rask-Madsen J. Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients. Lancet 1989; 1:1156 - 60; http://dx.doi.org/10.1016/S0140-6736(89)92749-9; PMID: 2566734
   PubMed Web of Science ®Google Scholar
• Petrof EO, et al. Stool Substitute transplant therapy for the eradication of Clostridium difficile infection: “RePOOPulating” the gut. Microbiome 2013; 1.
   Google Scholar
• Corthier G, Dubos F, Raibaud P. Modulation of cytotoxin production by Clostridium difficile in the intestinal tracts of gnotobiotic mice inoculated with various human intestinal bacteria. Appl Environ Microbiol 1985; 49:250 - 2; PMID: 3977313
   PubMed Web of Science ®Google Scholar
• Reeves AE, Koenigsknecht MJ, Bergin IL, Young VB. Suppression of Clostridium difficile in the gastrointestinal tracts of germfree mice inoculated with a murine isolate from the family Lachnospiraceae. Infect Immun 2012; 80:3786 - 94; http://dx.doi.org/10.1128/IAI.00647-12; PMID: 22890996
   PubMed Web of Science ®Google Scholar
• Nagaro KJ, Phillips ST, Cheknis AK, Sambol SP, Zukowski WE, Johnson S, Gerding DN. Nontoxigenic Clostridium difficile protects hamsters against challenge with historic and epidemic strains of toxigenic BI/NAP1/027 C. difficile. Antimicrob Agents Chemother 2013; 57:5266 - 70; http://dx.doi.org/10.1128/AAC.00580-13; PMID: 23939887
   PubMed Web of Science ®Google Scholar
• Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 1995; 125:1401 - 12; PMID: 7782892
   PubMed Web of Science ®Google Scholar
• Sullivan A, Nord CE. Probiotics in human infections. J Antimicrob Chemother 2002; 50:625 - 7; http://dx.doi.org/10.1093/jac/dkf194; PMID: 12407117
   PubMed Web of Science ®Google Scholar
• Johnston BC, Ma SS, Goldenberg JZ, Thorlund K, Vandvik PO, Loeb M, Guyatt GH. Probiotics for the prevention of Clostridium difficile-associated diarrhea: a systematic review and meta-analysis. Ann Intern Med 2012; 157:878 - 88; http://dx.doi.org/10.7326/0003-4819-157-12-201212180-00563; PMID: 23362517
   PubMed Web of Science ®Google Scholar